{"schema_version":"secwatch.filing_event.v1","accession":"0001664710-24-000069","form_type":"8-K","ticker":"KROS","cik":"0001664710","company_name":"Keros Therapeutics, Inc.","filed_at":"2024-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.026059+00:00","generated_at":"2026-05-31T11:48:28.030186+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Keros updates corporate deck; no material facts discernible from truncated exhibit","bullets":["Keros Therapeutics furnished an updated corporate presentation for investor meetings under Item 7.01.","The attached Exhibit 99.1 text is incomplete in the filing, preventing extraction of specific updates.","No financial results, clinical milestones, or guidance changes can be confirmed from available text.","The filing is a routine practice and does not indicate any material new development."],"urls":{"canonical":"https://secwatch.observer/filing/0001664710-24-000069","json":"https://secwatch.observer/filing/0001664710-24-000069.json","markdown":"https://secwatch.observer/filing/0001664710-24-000069.md","text":"https://secwatch.observer/filing/0001664710-24-000069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1664710/000166471024000069/0001664710-24-000069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1664710/000166471024000069/kros-20240807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:48:28.030186+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}